These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1284402)
21. Trimethoprim inhibition of the renal clearance of procainamide and N-acetylprocainamide. Vlasses PH; Kosoglou T; Chase SL; Greenspon AJ; Lottes S; Andress E; Ferguson RK; Rocci ML Arch Intern Med; 1989 Jun; 149(6):1350-3. PubMed ID: 2471472 [TBL] [Abstract][Full Text] [Related]
22. Comparison of transport of procainamide and N-acetylprocainamide from blood into the intestinal lumen with that into the peritoneal cavity in rats. Arimori K; Hashimoto Y; Nakano M Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):2050-2. PubMed ID: 1702691 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of very rapid emit Qst methods for measuring serum procainamide and N-acetylprocainamide concentrations. Carnes CA; Coyle JD Pharmacotherapy; 1992; 12(1):40-4. PubMed ID: 1372425 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment. Moffett BS; Cannon BC; Friedman RA; Kertesz NJ Pharmacotherapy; 2006 Dec; 26(12):1687-93. PubMed ID: 17125432 [TBL] [Abstract][Full Text] [Related]
26. Fluoroimmunoassays for procainamide and N-acetylprocainamide compared with a liquid-chromatographic method. MacKichan JJ; Coyle JD; Shields BJ; Boudoulas H; Lima JJ Clin Chem; 1984 May; 30(5):768-73. PubMed ID: 6201304 [TBL] [Abstract][Full Text] [Related]
27. Plasma concentrations of desethyl N-acetylprocainamide in patients treated with procainamide and N-acetylprocainamide. Ruo TI; Thenot JP; Stec GP; Atkinson AJ Ther Drug Monit; 1981; 3(3):231-7. PubMed ID: 6172888 [TBL] [Abstract][Full Text] [Related]
28. Improved high-performance liquid chromatographic assay for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetic study. Lessard E; Fortin A; Coquet A; Bélanger PM; Hamelin BA; Turgeon J J Chromatogr Sci; 1998 Jan; 36(1):49-54. PubMed ID: 9443381 [TBL] [Abstract][Full Text] [Related]
29. Comparison of the autonomic effects of procainamide and N-acetylprocainamide in the dog. Reynolds RD; Gorczynski RJ J Pharmacol Exp Ther; 1980 Mar; 212(3):579-83. PubMed ID: 6153717 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic and pharmacodynamic comparisons of twice daily and four times daily formulations of procainamide in patients with frequent ventricular premature depolarization. Yang BB; Abel RB; Uprichard AC; Smithers JA; Forgue ST J Clin Pharmacol; 1996 Jul; 36(7):623-33. PubMed ID: 8844445 [TBL] [Abstract][Full Text] [Related]
32. Ranitidine-induced changes in the renal and hepatic clearances of procainamide are correlated. Rocci ML; Kosoglou T; Ferguson RK; Vlasses PH J Pharmacol Exp Ther; 1989 Mar; 248(3):923-8. PubMed ID: 2467982 [TBL] [Abstract][Full Text] [Related]
33. Mandibular and parotid salivary excretion of procainamide and N-acetylprocainamide after intravenous administration of procainamide to rats. Watanabe J; Koyama I; Iwamoto K; Ozeki S J Pharm Pharmacol; 1987 Nov; 39(11):912-6. PubMed ID: 2448449 [TBL] [Abstract][Full Text] [Related]
34. Effect of age, gender, and race on steady state procainamide pharmacokinetics after administration of procanbid sustained-release tablets. Koup JR; Abel RB; Smithers JA; Eldon MA; de Vries TM Ther Drug Monit; 1998 Feb; 20(1):73-7. PubMed ID: 9485559 [TBL] [Abstract][Full Text] [Related]
35. Transport of procainamide and N-acetylprocainamide from blood into the intestinal lumen and intestinal dialysis by oral activated charcoal in rats with acute renal failure. Arimori K; Nakano M J Pharmacobiodyn; 1988 Jul; 11(7):504-11. PubMed ID: 2460613 [TBL] [Abstract][Full Text] [Related]
37. Prediction of N-acetylprocainamide disposition kinetics in rat by combination of gamma variate and physiological pharmacokinetic model. Liu XD; Deng N; Huang SK Zhongguo Yao Li Xue Bao; 1992 Mar; 13(2):97-103. PubMed ID: 1376015 [TBL] [Abstract][Full Text] [Related]
38. [Steady-state plasma and saliva concentrations of procainamide and N-acetyl-procainamide after a sustained release preparation]. Pirovino M; Karlaganis G; Galeazzi RL Schweiz Med Wochenschr; 1980 Sep; 110(39):1415-9. PubMed ID: 6169144 [TBL] [Abstract][Full Text] [Related]
39. [A new anti-arrhythmia drug. II. Comparative studies of the effects of a new acyl derivative of procainamide, procainamide and N-acetylprocainamide on blood pressure and the electrocardiogram in rabbits]. Kusowska J Acta Pol Pharm; 1989; 46(1):90-7. PubMed ID: 2479226 [TBL] [Abstract][Full Text] [Related]
40. [Verification of therapeutic levels of procainamide and N-acetyl- procainamide in ventricular arrhythmia]. Sinkiewicz W; Marzec A; Jankowski A; Hoffmann A; Makuch K; Romański B Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):458-60. PubMed ID: 1703654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]